Frank Pallone actually said...

"These provisions were based on the ideas and proposals contained in the Drug Safety Enhancement Act, which I introduced with Mr. Dingell, Mr. Waxman, and Ms. DeGette."

"I am eager to hear your testimony about FDA's progress in implementing the Food and Drug Administration Safety and Innovation Act, or FDASIA."

"It is important that American consumers have access to these safe, effective, and low cost alternatives more quickly, which is why the provisions in the generic drug user fee agreement were so importa..."

"I introduced a bill last year that included a provision to do just that and I have long been an advocate for the structural change within FDA to enhance the role of the Office of Generic Drugs."